Aventis COO Markham, Other Top Execs Depart As Sanofi Integration Begins
This article was originally published in The Pink Sheet Daily
Executive Summary
Aventis Vice Chairman and Chief Operating Officer Richard Markham is among the top Aventis execs leaving the company in the first phase of the integration with Sanofi
You may also be interested in...
Sanofi-Aventis Business Development Head Is Olivier Jacquesson
Jacquesson replaces Thomas Hofstaetter who announced his departure amidst the merger integration. Like Hofstaetter, Jacquesson previously served as an exec at Aventis where he was responsible for marketing activities in France.
Sanofi-Aventis Merger Complete
Sanofi-Aventis launches as the third largest pharmaceutical company in the world following completion of the Sanofi-Synthelabo/Aventis merger
Able Unable To Reform On Its Own? Firm Seeks Consent Decree To Address Manufacturing Issues
“We are prepared to enter discussions toward a decree at FDA’s earliest convenience,” Able says in letter to FDA. Company is pursuing consent decree instead of responding to FDA Form 483 report citing manufacturing deficiencies. The letter follows CEO Maury’s resignation the previous day.